New 2010 Impact Factors – Cell Press Established Performers and Rising Stars Deliver Top Class Performances
CAMBRIDGE, Mass., USA (June 28, 2011) – Whether it’s the established, leading journals, or the youngest rising stars, when it comes to impact factors Cell Press has delivered a top class performance, once again.
Cell Press is delighted to announce that its flagship journal Cell’s 2010 impact factor increased to 32.401 according to new data released in the Journal Citation Reports© published by ThomsonReuters (2010). The impact factor for Cell, the number one research journal in Cell Biology and Biochemistry & Molecular Biology, has climbed steadily over the last 5 years. Also from the June 28th report, the 2010 impact factor for Immunity is 24.221, an impressive 18% increase over last year.
Among Cell Press’s more recent suite of journal launches focusing on translational biomedical areas, Cancer Cell delivered another strong performance increasing by almost 7% to 26.925. Rising stars Cell Stem Cell and Cell Host & Microbe continue to grow from strength to strength in their third year of impact factors with Cell Stem Cell rising to 25.943 and Cell Host & Microbeincreasing to 13.728.
The 14 Trends review titles which joined Cell Press in 2007, also demonstrated significant increases in a number of subject areas. Leading lights include Trends in Biotechnology which grew 40% to 9.644, Trends in Ecology & Evolution which increased by 25% to 14.448, Trends in Genetics which increased by 31% to 11.364 and Trends in Endocrinology and Metabolism which increased by 29% to 8.479.
“We are delighted that the work published in Cell Press journals continues to be valued by the scientific community and to have a high impact in advancing new discoveries. Our sincere thanks go out to all the Cell Press authors and reviewers who have helped make this possible” said Emilie Marcus, Editor-in-Chief of Cell Press and Editor of Cell. “We’ve worked hard to deliver fast, fair and informed editorial services and to maintain our commitment to publishing the highest quality science while investing in new and improved services for our authors and readers, such as new online article formatsand mobile applications. We will continue to put the best science and innovation at the heart of everything we do.”
To read more about the 2010 impact factors from Cell Press go to www.cell.com/about.
About Cell Press
Cell Press, an imprint of Elsevier, is committed to improving scientific communication through the publication of exciting research and reviews. Each of our titles is viewed as a must-read by the scientific community it serves. Cell Press primary research journals include the flagship journal Cell, as well as Neuron, Immunity, Molecular Cell, Developmental Cell, Cancer Cell, Current Biology, Structure, Chemistry & Biology, Cell Metabolism, Cell Host & Microbe, Cell Stem Cell, and, new to Cell Press, Biophysical Journal, and The American Journal of Human Genetics. Cell Press also publishes the Trends family of reviews journals, includingTrends in Cell Biology, Trends in Neurosciences, and Trends in Cognitive Sciences. (ww.cell.com).
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com
Elisabeth (Lisa) Lyons
Press Office | Cell Press
+1 617-386-2121 (office)